losartan has been researched along with Chromosome Deletion in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Chromosome Deletion: Actual loss of portion of a chromosome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwai, N | 1 |
| Inagami, T | 1 |
1 other study available for losartan and Chromosome Deletion
| Article | Year |
|---|---|
Regulation of the expression of the rat angiotensin II receptor mRNA.
Topics: Actins; Adrenal Glands; Angiotensin II; Animals; Aorta; Biphenyl Compounds; Brain Stem; Cell Line; C | 1992 |